Biology

IIBR leads na​tional efforts to counter any and all biological threats from intentional attacks as well as naturally-emerging diseases. Using a multi-disciplinary project strategy, combined with cutting edge technologies, we develop methods for the identification of various bio-threats; forensic investigation of bio-terror agents and pathogenesis mech​anisms; design of new strategies for vaccine development, as well as evaluation of novel modalities of therapeutics. IIBR biotechnology cGMP multi-product facility, is designed for the development and production of bio-pharmaceuticals and unique vaccines for national preparedness. ​

EXPLORE
 

Environmental science

IIBR research and development concerning environmental sciences ranges from numerical mod​eling to laboratory and field​​​​ experiments in the areas of meteorology and atmospheric contaminants. IIBR has developed capabilities that enable detection and identification of hazardous materials, weather and dispersion prediction, physical protection and evaluation of potential risks.

EXPLORE
 

Chemistry

Toxicological eval​uation at IIBR is followed by the generation of novel treatment protocols and drugs, rapid and effective solutions for damage prevention and control. These are g​ained by a combination of cutting-edge synthetic capabilities and an advanced analytical toolbox. All are based on comprehensive pharmacological and pathophysiological understanding and advanced experimental means.​

EXPLORE
 
Collaborate

PHD

Women In Science

0

Fields of scientific knowledge

0

Last decade publications

The President to the state of Israel's visit to The Israel Institute for biological research (IIBR)

​During the president’s visit, IIBR’s scientist revealed that they have completed a groundbreaking scientific development determining a set of antibodies that neutralize the novel corona virus.
The president to the state of Israel: “The process is complex and long but your breakthrough is an important scientific millstone toward victory”. ​
 

 

Worldwide breakthrough: The Israel institute for biological research’s scientists have managed to isolate a specific monoclonal antibody that is able to effectively neutralize COVID19.

​IIBR, using its Biology division's well-established platform for antibody engineering, have managed to isolate monoclonal antibody against the virus, from blood samples that were obtain from severe COVID19 patients. It was also demonstrated that this antibody was able to effectively neutralize the virus. Parallel efforts are being made worldwide. Some have managed to isolate antibodies that neutralize other closely related viruses and even anti-SARS-CoV-2 monoclonal antibodies, but IIBR is the first to demonstrate that the antibody that was isolated from COVID19 patient can indeed neutralize this pathogen. IIBR will continue to characterize this antibody and others and a biological manufacture would be sought to mass produce it for clinical use.​​

 

 

The Israel Institute for biological research take on the corona virus's ability to survive on surfaces in low-temperature conditions

​IIBR researchers found that in heat conditions, characterized by the Israeli summer, the virus can survive on the surfaces for several hours compared to a few days at lower temperatures. In their opinion, there is no need for extensive disinfecting of the public spaces towards returning to the work routine 

 

 

Collaboration between IIBR and Shaarey Zedek Medical Center explores a new method for detecting corona's markers through human breath analysis

​Hundreds of volatile chemical compounds are exhaled in breath. In order to find markers specific for Corona, they need to be detected, identified and mapped.

IIBR has developed unique methods for sensitive analysis and comprehensive data processing that are used in order to reliably identify these markers.

 

 

The Israel Institute for Biological Research and the Weizmann Institute of Science Have Signed a Memorandum of Understanding to Collaborate in the Fight against Coronavirus

​The Israel​​ Institute for Biological Research and the Weizmann Institute of Science will join efforts in advancing research designed to develop ways to combat the coronavirus. A Memorandum of Understanding (MoU) between the two Institutes on this matter has been signed in recent days.​

 

 

Newsroom

Scientific Publications

​IIBR's latest Scientific Publications in the fields of biology, chemistry and the environmental sciences​.

read moreaboutScientific Publications

News

​Read about IIBR in the press.





read moreaboutNews